Significant Ownership of SAMLYN CAPITAL, LLC
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for SAMLYN CAPITAL, LLC focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager location
- New York, NY
- Manager signature
- By: Samlyn, LP, its sole member, By: Samlyn GP, LLC, its general partner, By: /s/ Robert Pohly* - Robert Pohly, Managing Member
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow SAMLYN CAPITAL, LLC with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from SAMLYN CAPITAL, LLC
Significant Ownership of SAMLYN CAPITAL, LLC
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| VINP | Vinci Partners Investments Ltd. | Class A Common Shares, par value US$0.00005 per share | 4.8% | $22,695,339 | -$34,013 | 2,356,733 | -0.15% | SAMLYN CAPITAL, LLC | 31 Mar 2025 |
| PCT | PureCycle Technologies, Inc. | Common Stock, par value $0.001 per share | 4.2% | $48,960,458 | -$35,642,845 | 7,896,848 | -42% | SAMLYN CAPITAL, LLC | 31 Mar 2026 |
| NKTR | Nektar Therapeutics | Common Stock, $0.0001 par value | 0% | $0 | -$7,153,616 | 0 | -100% | SAMLYN CAPITAL, LLC | 31 Mar 2025 |
| CRVS | Corvus Pharmaceuticals, Inc. | Common Stock, par value $0.0001 per share | 0% | $0 | -$15,857,146 | 0 | -100% | SAMLYN CAPITAL, LLC | 30 Jun 2025 |
| INZY | Inozyme Pharma, Inc. | Common Stock, par value $0.0001 per share | 0% | $0 | 0 | Samlyn Capital, LLC | 31 Dec 2024 |
Schedules 13D/G Reported by SAMLYN CAPITAL, LLC:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.